Patanjali Ayurved Ramdev

TMS Ep640: SC on Patanjali, Blinkit, Vodafone Idea stock, CBAM

Where does the buck stop after SC rap on Patanjali? Can Blinkit challenge Amazon & Flipkart? Why did Vodafone Idea's fundraise plan fail? What is the Carbon Border Adjustment Mechanism? Answers here

Nepal blacklists 16 Indian pharma companies, including Ramdev's Pharmacy

Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products, stating that they failed to comply with the World Health Organisation's (WHO) drug manufacturing standards. The Department of Drug Administration, in a notice issued on December 18 asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them. According to the notice issued by the Department, the medicines manufactured by the listed companies cannot be imported or distributed in Nepal. The list of the companies that do not comply with WHO standards were published after inspection of the manufacturing facilities of the pharmaceutical companies that had applied to export their products to Nepal, according to the Department officials. In April and July, the Department sent a team of drug inspectors to India to inspect the manufacturing facilities of pharmaceutical companies that

Delhi HC to hear plea against Ramdev for remarks against allopathy

The Delhi High Court will hear on Monday a plea by seven doctors' associations against Yoga guru Ramdev for allegedly spreading misinformation by his statements against allopathy amid the ongoing COVID-19 pandemic. The matter will be heard by Justice C Hari Shankar who had earlier asked the counsel for the associations to place on record the videos pertaining to the alleged misinformation. The associations before court are three Resident Doctors' Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneshwar, Association of Resident Doctors, Post Graduate Institute of Medical Education & Research, Chandigarh, Union of Resident Doctors of Punjab (URDP); Resident Doctors' Association, Lala Lajpat Rai Memorial Medical College, Meerut and Telangana Junior Doctors' Association, Hyderabad. They alleged that Ramdev was misleading and misrepresenting to the public at large that allopathy was responsible for the deaths of several people infected by ...

Patanjali Ayurved raises Rs 175 cr through non-convertible debentures

Baba Ramdev-led Patanjali Ayurved on Tuesday said it has raised Rs 175 crore by issuing non-convertible debentures (NCDs).

Top headlines: GST cut for auto sector unlikely, Happiest Minds IPO shines

Business Standard brings you the top headlines of the day

From Patanjali's claim to U-turn on Coronil: Sequence of events

On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days

Ruchi Soya soared 90 times in 5 months; should you buy?

From Rs 16.9 to Rs 1,519 in five months, the stock has seen a spectacular rise of 8,988 per cent

Rajasthan cops charge Ramdev, Patanjali MD with cheating for Covid-19 drug

Haridwar-based Patanjali Ayurved on Tuesday launched "Coronil", claiming it can cure COVID-19

Coronavirus updates: Over 17,000 new cases, record recoveries in India

India death toll crosses 15,000; Maharashtra, Delhi, Tamil Nadu account for 68% of cases added today

Amid 'Coronil' row, Ramdev's Patanjali insists it broke no regulations

The Haridwar-based company on Tuesday launched "Coronil", claiming it can cure Covid-19

India-US 'green' corridor for air travel, and other coronavirus updates

The total number of Covid-19 cases in Delhi crossed the 66,000 mark, with the biggest single-day spike of 3,947 fresh infections being reported on Tuesday

Good that Ramdev has given Covid-19 medicine, but rules matter: Minister

The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on Covid-19 with AYUSH interventions/medicines should be undertaken

Govt asks Ramdev's Patanjali group to stop Covid-19 drug ads, seeks details

Hours after the launch, the ministry denied knowledge of the drugs and asked the group to refrain from publicising them.

India tally rises to 440K; Patanjali launches ayurvedic drug for Covid-19

According to government data, the situation in India is not as alarming as some of the other countries, given a limited spread on a per-capita basis

Low number of free-float pushes Ruchi Soya Industries to record high

The edible oil maker's market capitalisation is up nearly 300 times since the beginning of November last year and 70 times since its acquisition by Pantanjali Ayurved under the IBC

Patanjali's Rs 250 crore NCD subscribed within three minutes of opening

The fund-raising will be used to meet the Haridwar-based company's working capital requirements and strengthen the supply chain network

UP announces subsidy for Patanjali's Rs 6,000 cr food park in Greater Noida

Food park will come up over 91 acres near Yamuna Expressway

Patanjali's Apr-Sep revenue at Rs 3,562 cr, highest for a half-year period

The company had reported a revenue of Rs 937 crore and Rs 1,576 crore in June quarter and September quarter of 2018-19, respectively.

Care Ratings downgrades Ramdev's Patanjali on Ruchi Soya acquisition

Care Ratings Ltd. downgraded Patanjali's long-term bank facilities to A- from A+, according to a statement on Friday

What ails Baba Ramdev's Patanjali Ayurved?

According to a recent IIFL report, sales of Patanjali products have halved from two year earlier levels.